Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
37740
CAS Number:
59721-29-8
Mésylate de camostat
Purity:
≥ 98 % (HPLC)
Synonym(s):
Méthanesulfonate de camostat, Mésylate de Foipan
Documents
$108.36 /25 mg
Taille
Request Bulk Quote
Informations sur le produit

Camostat mesylate is a potent serine protease inhibitor recognized for its diverse applications in both research and clinical settings. This compound has garnered attention for its potential therapeutic effects, particularly in the treatment of various viral infections, including its role as a promising candidate against SARS-CoV-2. Its unique mechanism of action involves the inhibition of proteases that are essential for viral entry into host cells, making it a valuable tool in antiviral research. Additionally, camostat mesylate has been explored for its anti-inflammatory properties, which can be beneficial in managing conditions such as pancreatitis and fibrosis.

Researchers and industry professionals will appreciate camostat mesylate's versatility in drug development and its potential to enhance therapeutic strategies. Its ability to modulate protease activity opens avenues for innovative treatments in infectious diseases and beyond. With ongoing studies highlighting its efficacy and safety, camostat mesylate stands out as a compound with significant promise for future applications in pharmacology and therapeutic interventions.

Numéro CAS 
59721-29-8
Formule moléculaire
C20H22N4O5 · CH4O3S
Poids moléculaire 
494.52
Point de fusion 
196 - 200 °C
Informations générales
Numéro CAS 
59721-29-8
Formule moléculaire
C20H22N4O5 · CH4O3S
Poids moléculaire 
494.52
Point de fusion 
196 - 200 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Camostat mesylate is widely utilized in research focused on:

  • COVID-19 Treatment: This compound has gained attention for its potential to inhibit the entry of SARS-CoV-2 into cells, making it a candidate for therapeutic use in managing COVID-19.
  • Pancreatitis Management: It is used in the treatment of acute pancreatitis, helping to reduce inflammation and improve patient outcomes.
  • Fibrosis Research: Camostat mesylate is being studied for its effects on fibrosis, particularly in liver and kidney diseases, offering hope for new treatment strategies.
  • Drug Delivery Systems: Its properties allow for the development of innovative drug delivery methods, enhancing the effectiveness of various medications.
  • Cancer Research: The compound is also being explored for its potential anti-cancer properties, particularly in inhibiting tumor growth and metastasis.

Citations